Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Heyckendorf

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Infection|January 5, 2020
Intensified adjunctive corticosteroid therapy for CNS tuberculomasIsabelle Suárez, Henning Gruell, Jan Heyckendorf, et al.
Innere Medizin (Heidelberg, Germany)|June 14, 2023
[Treatment of tuberculosis: what is new?]Thomas Theo Brehm, Niklas Köhler, Stefan Schmiedel, et al.
Scientific Reports|April 29, 2014
Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertensionJan K Hennigs, Hans Jörg Baumann, Nicole Lüneburg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2020
Pulmonary vasculitis due to infection with Mycobacterium goodii: A case reportElena Pfeuffer-Jovic, Jan Heyckendorf, Udo Reischl, et al.
Journal of Health, Population, and Nutrition|December 22, 2024
Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort studyRupa Ramachandran, Andreea Dumitrescu, Dragos Baiceanu, et al.
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Respiration; International Review of Thoracic Diseases|June 29, 2018
Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary DiseaseHelmut J F Salzer, Gerd Burchard, Oliver A Cornely, et al.
The Journal of Infection|December 29, 2024
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/RifMarit Neumann, Maja Reimann, Dumitru Chesov, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Frontiers in Microbiology|October 19, 2018
Evaluation of Galactomannan Testing, the <i>Aspergillus</i>-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary AspergillosisHelmut J F Salzer, Juergen Prattes, Holger Flick, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Infection|January 5, 2020
Intensified adjunctive corticosteroid therapy for CNS tuberculomasIsabelle Suárez, Henning Gruell, Jan Heyckendorf, et al.
Innere Medizin (Heidelberg, Germany)|June 14, 2023
[Treatment of tuberculosis: what is new?]Thomas Theo Brehm, Niklas Köhler, Stefan Schmiedel, et al.
Scientific Reports|April 29, 2014
Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertensionJan K Hennigs, Hans Jörg Baumann, Nicole Lüneburg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2020
Pulmonary vasculitis due to infection with Mycobacterium goodii: A case reportElena Pfeuffer-Jovic, Jan Heyckendorf, Udo Reischl, et al.
Journal of Health, Population, and Nutrition|December 22, 2024
Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort studyRupa Ramachandran, Andreea Dumitrescu, Dragos Baiceanu, et al.
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Respiration; International Review of Thoracic Diseases|June 29, 2018
Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary DiseaseHelmut J F Salzer, Gerd Burchard, Oliver A Cornely, et al.
The Journal of Infection|December 29, 2024
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/RifMarit Neumann, Maja Reimann, Dumitru Chesov, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Frontiers in Microbiology|October 19, 2018
Evaluation of Galactomannan Testing, the <i>Aspergillus</i>-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary AspergillosisHelmut J F Salzer, Juergen Prattes, Holger Flick, et al.
Pageof 7